In addition, activation of the mGPDH/AMPK/mitochondrial biogenesis pathway of skeletal muscle may represent a new mechanism for treatment during obesity and diabetes. This evidence concerns the gene GPD2 and obesity due to melanocortin 4 receptor deficiency.